Naruya Tomita Selected Research

Naruya Tomita Research Topics

Disease

5	Cardiovascular Diseases (Cardiovascular Disease) 04/2006 - 10/2002
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011 - 10/2007
4	Glomerulonephritis 02/2007 - 07/2000
3	Proteinuria 03/2012 - 07/2000
3	Chronic Renal Insufficiency 01/2011 - 02/2008
3	Hypertension (High Blood Pressure) 09/2009 - 04/2007
3	Neoplasms (Cancer) 04/2008 - 04/2006
3	Wounds and Injuries (Trauma) 10/2007 - 11/2002
3	Hypercholesterolemia 10/2007 - 08/2002
3	Coronary Disease (Coronary Heart Disease) 10/2002 - 05/2002
2	Hypertrophy 04/2011 - 09/2009
2	Hypoxia (Hypoxemia) 02/2011 - 10/2004
2	Vascular System Injuries 01/2011 - 10/2007
2	Sclerosis 09/2010 - 02/2008
2	Albuminuria 04/2008 - 09/2002
2	Colonic Neoplasms (Colon Cancer) 04/2008 - 04/2006
2	Fibrosis (Cirrhosis) 04/2008 - 06/2003
2	Arthritis (Polyarthritis) 06/2006 - 01/2006
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2011
1	Lipoprotein Glomerulopathy 01/2011
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2011
1	Neoplasm Metastasis (Metastasis) 04/2008
1	Inflammation (Inflammations) 04/2008
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2008
1	Abdominal Aortic Aneurysm 02/2008
1	Stomach Neoplasms (Stomach Cancer) 10/2007
1	Body Weight (Weight, Body) 04/2007
1	Cardiomegaly (Heart Hypertrophy) 04/2007
1	Renal Insufficiency (Renal Failure) 02/2007
1	Rheumatoid Arthritis 08/2006
1	Infarction (Infarctions) 04/2006
1	Atopic Dermatitis (Atopic Eczema) 04/2006

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 04/2011 - 06/2003
4	NF-kappa B (NF-kB)IBA 04/2008 - 07/2000
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011 - 11/2003
3	OligonucleotidesIBA 10/2007 - 05/2003
3	Liposomes (Liposome)IBA 11/2002 - 08/2002
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2010 - 09/2009
2	NADPH Oxidases (NAD(P)H oxidase)IBA 09/2010 - 06/2006
2	Dietary ProteinsIBA 05/2009 - 10/2007
2	Angiotensin II Type 1 Receptor BlockersIBA 04/2008 - 10/2007
2	NF-kappaB decoyIBA 04/2008 - 07/2000
2	Pioglitazone (Actos)FDA Link 04/2008 - 10/2007
2	DNA (Deoxyribonucleic Acid)IBA 04/2008 - 04/2006
2	Superoxides (Superoxide)IBA 02/2008 - 06/2006
2	Nifedipine (Adalat)FDA LinkGeneric 02/2008 - 01/2006
2	Therapeutic UsesIBA 10/2007 - 04/2006
2	Antihypertensive Agents (Antihypertensives)IBA 10/2007 - 01/2006
2	OligodeoxyribonucleotidesIBA 08/2006 - 04/2006
2	CytokinesIBA 04/2006 - 07/2000
2	FS 069 (Optison)FDA Link 01/2004 - 06/2003
2	Messenger RNA (mRNA)IBA 06/2003 - 11/2002
2	Transcription Factors (Transcription Factor)IBA 05/2003 - 07/2000
1	Amlodipine (Norvasc)FDA LinkGeneric 03/2012
1	azelnidipineIBA 03/2012
1	Insulin (Novolin)FDA Link 04/2011
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2011
1	8-Hydroxy-2'-DeoxyguanosineIBA 02/2011
1	myxothiazolIBA 02/2011
1	Mitochondrial DNA (mtDNA)IBA 02/2011
1	Angiotensin Receptor AntagonistsIBA 01/2011
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2011
1	Lipoproteins (Lipoprotein)IBA 01/2011
1	Protein Isoforms (Isoforms)IBA 01/2011
1	Apolipoprotein E2IBA 01/2011
1	salicylhydroxamic acid (SHAM)IBA 09/2010
1	AlbuminsIBA 09/2010
1	tempolIBA 09/2009
1	Ribosomal Protein S6IBA 09/2009
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 04/2008
1	ElementsIBA 04/2008
1	candesartanIBA 04/2008
1	Streptozocin (Streptozotocin)FDA Link 04/2008
1	AdiponectinIBA 04/2008
1	sarpogrelateIBA 04/2008
1	ThiazolidinedionesIBA 04/2008
1	Complementary DNA (cDNA)IBA 04/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2008
1	Serotonin (5 Hydroxytryptamine)IBA 04/2008
1	2,4-thiazolidinedione (thiazolidinedione)IBA 10/2007
1	olmesartanIBA 10/2007
1	Proto-Oncogene Protein c-ets-1IBA 10/2007
1	Hydralazine (Apresoline)FDA LinkGeneric 10/2007
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2007
1	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2007
1	imidaprilIBA 04/2007
1	Antigen-Antibody Complex (Immune Complex)IBA 02/2007
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 06/2006
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 04/2006
1	TCF Transcription FactorsIBA 04/2006
1	beta CateninIBA 04/2006
1	Cyclin D1IBA 04/2006
1	Matrix Metalloproteinases (MMPs)IBA 01/2006

Therapy/Procedure

6	Therapeutics 09/2009 - 11/2004
2	Nephrectomy 04/2011 - 09/2009
2	Microbubbles 01/2004 - 06/2003
1	Sympathectomy (Sympathectomies) 09/2010
1	High-Protein Diet 04/2008
1	Intraperitoneal Injections 10/2007
1	Drug Therapy (Chemotherapy) 01/2006